Fiduciary Alliance’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Buy |
21,043
+4,117
| +24% | +$764K | 0.29% | 83 |
|
|
2025
Q1 | $3.55M | Buy |
16,926
+1,079
| +7% | +$226K | 0.35% | 71 |
|
|
2024
Q4 | $2.82M | Buy |
15,847
+10,947
| +223% | +$1.95M | 0.28% | 85 |
|
|
2024
Q3 | $968K | Buy |
4,900
+979
| +25% | +$193K | 0.13% | 112 |
|
|
2024
Q2 | $651K | Buy |
3,921
+1,481
| +61% | +$246K | 0.11% | 109 |
|
|
2024
Q1 | $441K | Sell |
2,440
-164
| -6% | -$29.6K | 0.08% | 132 |
|
|
2023
Q4 | $404K | Sell |
2,604
-38
| -1% | -$5.89K | 0.08% | 126 |
|
|
2023
Q3 | $394K | Buy |
2,642
+407
| +18% | +$60.7K | 0.09% | 119 |
|
|
2023
Q2 | $301K | Buy |
2,235
+904
| +68% | +$122K | 0.06% | 127 |
|
|
2023
Q1 | $212K | Sell |
1,331
-11
| -0.8% | -$1.75K | 0.05% | 127 |
|
|
2022
Q4 | $217K | Buy |
+1,342
| New | +$217K | 0.06% | 125 |
|